Study S000667

Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06854614
Acronym: STAY-LEAN
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 150
Start: 2025-03-01
Primary completion: 2027-04-28
Lead sponsor: The Cleveland Clinic
Conditions: Obesity
Interventions: OTHER:Comprehensive weight loss; OTHER:Enhanced lifestyle changes; DRUG:Tirzepatide; DRUG:Naltrexone-Bupropion; DRUG:Phentermine-Topiramate; DRUG:Semaglutide (Wegovy®)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Weight change [month 9 to month 21]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.